SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-253650
Filing Date
2015-07-15
Accepted
2015-07-15 16:18:10
Documents
4
Period of Report
2015-07-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d74071d8k.htm 8-K 19880
2 EX-99.1 d74071dex991.htm EX-99.1 11823
3 GRAPHIC g74071g00l41.jpg GRAPHIC 4985
4 GRAPHIC g74071g11s35.jpg GRAPHIC 5769
  Complete submission text file 0001193125-15-253650.txt   47924
Mailing Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS INC (Filer) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36070 | Film No.: 15989485
SIC: 2834 Pharmaceutical Preparations